FAS and cancer: More recently, TNFα-superfamily death receptor named Fas (CD95) has become the focus of attention due to the critical role of Fas ligand (FasL) on the surface of CAR-T cells in instigating bystander killing of antigen−/FasR+ cancer cells in leukemia clinical trials8–10.